News

CHOSA Oncology AB presenterar kvartalsrapport 3 2024

Regulatory press release

[Read more]

Bulletin from the extraordinary general meeting on 23 October 2024 in Chosa Oncology AB

Regulatory press release

[Read more]

Kommuniké från extra bolagsstämma den 23 oktober 2024 i Chosa Oncology AB

Regulatory press release

[Read more]

Notice of extraordinary general meeting in Chosa Oncology AB

Regulatory press release

[Read more]

Kallelse till extra bolagsstämma i Chosa Oncology AB

Regulatory press release

[Read more]

Renowned oncologist, Professor Fred R. Hirsch, MD, PhD, has accepted the nomination to the Board of Directors of CHOSA

[Read more]

Den internationellt erkända onkologen, Professor Fred R. Hirsch, MD, PhD, har accepterat nomineringen till CHOSAs styrelse

[Read more]

CHOSA Oncology AB presenterar kvartalsrapport 2 2024

Regulatory press release

[Read more]

Kommuniké från årsstämma den 31 maj 2024 i Chosa Oncology AB

Regulatory press release

[Read more]

CHOSA Oncology AB presenterar kvartalsrapport 1 2024

Regulatory press release

[Read more]

CHOSA AB publicerar sin årsredovisning för 2023

Regulatory press release

[Read more]

Notice of annual general meeting in Chosa Oncology AB

Regulatory press release

[Read more]

Kallelse till årsstämma i Chosa Oncology AB

Regulatory press release

[Read more]

CHOSA has carried out a directed issue of SEK 5,58 million to fund KOL-initiated DRP validation studies and to increase business development activities

Regulatory press release

[Read more]

CHOSA har genomfört en riktad emission på 5,58 miljoner SEK för att finansiera KOL-initierade DRP-valideringsstudier och för ökade affärsutvecklingsaktiviteter

Regulatory press release

[Read more]

Chosa Oncology – Appoints Chief Commercial Officer and new Chief Financial Officer

Regulatory press release

[Read more]

Chosa Oncology - Utser Chief Commercial Officer och ny Chief Financial Officer

Regulatory press release

[Read more]

CHOSA Oncology AB - Bokslutskommuniké januari-december 2023

Regulatory press release

[Read more]

CHOSA Oncology AB’s postpones publication of the interim report Q4 2024

Regulatory press release

[Read more]

CHOSA Oncology AB senarelägger publiceringen av delårsrapporten för fjärde kvartalet 2024

Regulatory press release

[Read more]

CHOSA Oncology AB receives tax credit of 7.8 mSEK

Regulatory press release

[Read more]

CHOSA Oncology AB får utbetalat en skattekredit på 7,8 mSEK från Danska Skattemyndigheten

Regulatory press release

[Read more]

CHOSA Oncology AB presenterar kvartalsrapport 3 2023

Regulatory press release

[Read more]

CHOSA Oncology AB has carried out a directed issue of SEK 1,55 million to further increase business development activities

Regulatory press release

[Read more]
Show news before 2023